Distinct Transcriptomic and Tumor Microenvironment Profiles in Sinonasal Mucosal Melanoma and Aggressive Cutaneous Melanomas
2024

Distinct Profiles in Sinonasal Mucosal Melanoma and Aggressive Cutaneous Melanomas

Sample size: 37 publication 10 minutes Evidence: moderate

Author Information

Author(s): Molina-García Manuel, Rojas-Lechuga María Jesús, Torres Moral Teresa, Bagué Jaume, Mateu Judit, Langdon Cristóbal, Lop Joan, Gonçalves de Souza Vinícius, Alós Llúcia, López-Chacón Mauricio, Podlipnik Sebastian, Carrera Cristina, Malvehy Josep, Alobid Isam, da Silva-Júnior Rui Milton Patricio, Puig Susana

Primary Institution: Hospital Clinic of Barcelona

Hypothesis

This study aimed to identify the molecular features of sinonasal mucosal melanoma (SNMM) to understand its aggressive behavior and improve treatment strategies.

Conclusion

The study found that sinonasal mucosal melanoma has a unique genetic profile that may help explain its poor prognosis and could lead to new treatment approaches.

Supporting Evidence

  • Sinonasal mucosal melanoma has a 5-year melanoma-specific survival rate below 40%.
  • The study identified 602 differentially expressed genes related to cell cycle and immune pathways.
  • Cluster B, which included all sinonasal mucosal melanomas, showed poorer melanoma-specific survival compared to cluster A.
  • Patients with sinonasal mucosal melanoma had a higher mitotic index and fewer BRAF mutations.
  • Immune scores were significantly lower in sinonasal mucosal melanoma compared to cutaneous melanoma.

Takeaway

This study looked at a rare type of skin cancer called sinonasal mucosal melanoma and found that it behaves differently from more common skin melanomas, which might help doctors treat it better.

Methodology

The study analyzed 37 primary melanoma tumors using next-generation sequencing and various statistical methods to assess gene expression and survival outcomes.

Limitations

The study had a relatively small cohort size due to the rarity of sinonasal mucosal melanoma and used a specific gene panel that may not cover all relevant genes.

Participant Demographics

The study included 40 patients with a median age of 63.9 years, comprising 70.3% male and 29.7% female participants.

Statistical Information

P-Value

p = 0.0029

Confidence Interval

95%CI = 12.0–55.9

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244172

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication